New Key Statistics Module, Z-Score and F-Score
NAS:BMRN Key Ratios
Market Cap $ M | 15,334.69 |
Enterprise Value $ M | 15,644.78 |
P/E(ttm) | 75.48 |
PE Ratio without NRI | 42.33 |
Forward PE Ratio | 30.34 |
Price/Book | 3.02 |
Price/Sales | 6.31 |
Price/Free Cash Flow | 95.48 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 2,471.00 |
EPS (TTM) $ | 1.07 |
Beneish M-Score | -2.45 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 86.10 |
EV-to-EBIT | 61.61 |
EV-to-EBITDA | 43.55 |
PEG | -- |
Shares Outstanding M | 189.88 |
Net Margin (%) | 8.31 |
Operating Margin % | 7.17 |
Pre-tax Margin (%) | 9.60 |
Quick Ratio | 1.70 |
Current Ratio | 2.74 |
ROA % (ttm) | 3.07 |
ROE % (ttm) | 4.22 |
ROIC % (ttm) | 2.99 |
Dividend Yield % | -- |
Altman Z-Score | 5.91 |
BMRN Number of Guru Trades
BMRN Volume of Guru Trades
Gurus Latest Trades with NAS:BMRN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BMRN is held by these investors
Total 5
Biomarin Pharmaceutical Inc Insider Transactions
No Available Data
News about NAS:BMRN
Total 0- 1